Epigenetic Biomarkers in Gallbladder Cancer

Espinoza, 2015, Molecular genetics of gallbladder cancer, 1 Dawson, 2012, Cancer epigenetics: from mechanism to therapy, Cell, 150, 12, 10.1016/j.cell.2012.06.013 Tekcham, 2016, Epigenetic regulation in gallbladder cancer: promoter methylation profiling as emergent novel biomarkers, Asia Pac. J. Clin. Oncol., 12, 332, 10.1111/ajco.12507 Fardi, 2018, Epigenetic mechanisms as a new approach in cancer treatment: an updated review, Genes Dis., 5, 304, 10.1016/j.gendis.2018.06.003 Sharma, 2016, Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease, Tumor Biol., 37, 14687, 10.1007/s13277-016-5355-9 Wang, 2018, Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage, Clin. Epigenetics, 10, 59, 10.1186/s13148-018-0492-1 López-Urrutia, 2019, Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer, Front. Oncol., 9, 669, 10.3389/fonc.2019.00669 Arun, 2018, Therapeutic targeting of long non-coding RNAs in cancer, Trends Mol. Med., 24, 257, 10.1016/j.molmed.2018.01.001 Tekcham, 2016, Non-coding RNAs as emerging molecular targets in gallbladder cancer, Gene, 588, 79, 10.1016/j.gene.2016.04.047 Yang, 2016, The role of microRNAs in gallbladder cancer (review), Mol. Clin. Oncol., 5, 7, 10.3892/mco.2016.905 Li, 2015, MicroRNA signatures in total peripheral blood of gallbladder cancer patients, Tumour Biol., 36, 6985, 10.1007/s13277-015-3412-4 Mohammad, 2019, Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer, Nat. Med., 25, 403, 10.1038/s41591-019-0376-8 Rajesha, 2017, MicroRNA therapeutics: towards a new era for the management of cancer and other diseases, Nat. Rev. Drug Discov., 16, 203, 10.1038/nrd.2016.246 Zhua, 2019, Sex disparities in cancer, Canc. Lett., 466, 35, 10.1016/j.canlet.2019.08.017 Prashanth, 2019, Epidemiology of gallbladder cancer, Clin. Exp. Hepatol., 5, 93, 10.5114/ceh.2019.85166